Algorae Pharmaceuticals Limited (ASX:1AI)
Australia
· Delayed Price · Currency is AUD 0.0130
-0.0010 (-7.14%)
Mar 10, 2026, 4:10 PM AEST
Algorae Pharmaceuticals Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Revenue | -0.03 | - | - | - | 0 | 0.27 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | -98.73% | -51.56% | Upgrade
|
| Gross Profit | -0.03 | - | - | - | 0 | 0.27 | Upgrade
|
| Selling, General & Admin | 0.16 | 0.18 | 0.2 | 0.21 | - | - | Upgrade
|
| Research & Development | 1.04 | 0.85 | 0.74 | 1.31 | 1.46 | 1.61 | Upgrade
|
| Operating Expenses | 1.44 | 1.07 | 1.7 | 1.52 | 1.46 | 1.61 | Upgrade
|
| Operating Income | -1.46 | -1.07 | -1.7 | -1.52 | -1.46 | -1.34 | Upgrade
|
| Interest Expense | -0 | -0 | - | - | - | - | Upgrade
|
| Interest & Investment Income | 0.14 | 0.14 | 0.13 | 0.04 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.09 | 0.02 | -0.02 | -0.02 | 0.01 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.72 | -0.63 | -0.5 | -0.61 | -0.91 | -0.67 | Upgrade
|
| EBT Excluding Unusual Items | -2.14 | -1.54 | -2.09 | -2.11 | -2.36 | -2.01 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | - | 0.11 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -0 | - | -0.01 | - | Upgrade
|
| Pretax Income | -2.14 | -1.54 | -2.1 | -2.11 | -2.37 | -1.91 | Upgrade
|
| Income Tax Expense | -1.12 | -0.74 | - | - | -0.41 | -0.44 | Upgrade
|
| Net Income | -1.01 | -0.8 | -2.1 | -2.11 | -1.96 | -1.46 | Upgrade
|
| Net Income to Common | -1.01 | -0.8 | -2.1 | -2.11 | -1.96 | -1.46 | Upgrade
|
| Shares Outstanding (Basic) | 1,735 | 1,687 | 1,663 | 1,347 | 876 | 571 | Upgrade
|
| Shares Outstanding (Diluted) | 1,735 | 1,687 | 1,663 | 1,347 | 876 | 571 | Upgrade
|
| Shares Change (YoY) | 4.60% | 1.46% | 23.47% | 53.82% | 53.24% | - | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Free Cash Flow | -0.7 | -0.79 | -1.52 | -1.99 | -2.05 | -1.46 | Upgrade
|
| Free Cash Flow Per Share | - | - | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Gross Margin | - | - | - | - | 100.00% | 100.00% | Upgrade
|
| Operating Margin | - | - | - | - | -42870.16% | -500.05% | Upgrade
|
| Profit Margin | - | - | - | - | -57483.11% | -544.62% | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | -60088.31% | -544.97% | Upgrade
|
| EBITDA | - | - | -1.7 | -1.52 | -1.46 | -1.34 | Upgrade
|
| D&A For EBITDA | - | - | 0 | 0 | 0 | 0 | Upgrade
|
| EBIT | -1.46 | -1.07 | -1.7 | -1.52 | -1.46 | -1.34 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.